Fatemeh Kaveh
- Postdoc; PhD, MSc
- +47 22 78 23 19
NFR CellFit
Education:
2008 – 2013: PhD in Bioinformatics – Genetics, Genomics signatures in progression of breast cancer with reference to gynecological carcinomas, Faculty of Medicine,University of Oslo, Norway.
2005 – 2007: Master of Science in Bioinformatics and System Biology, Department of Mathematics, Chalmers University, Göteborg, Sweden.
1994 – 1999: Bachelor of Science in Medical Engineering (Bio-Electric), Azad University, Tehran, Iran.
Work experience:
03/2022 – Present: Postdoc, Department of Cellular Therapy, OUS-Radiumhospitalet, Oslo, Norway.
2018 – 2021: Postdoc, BigMed Project (RNA-Seq pipeline), Department of Tumor Biology, OUS-Radiumhospitalet, Oslo, Norway.
2013 – 2018: Postdoc, Qualitative and quantitative HLA data from next generation sequencing, Department of Medicine Genetics, OUS-Ullevål hospital, Oslo, Norway.
05/2015 – 11/2015: Postdoc, Whole genome and exome sequencing of childhood cancer, Department of Pediatric Research, Women and Children's Division, Rikshospitalet, Oslo, Norway.
2008 – 2013: PhD Student (Research), analysis of whole genome variation (SNPs & CNVs) in relation to the risk and progression of breast cancer with reference to gynecological carcinomas, Institute of cancer research, Department of Genetics, OUS-Radiumhospitalet, Oslo, Norway.
2006 – 2007: Research (Master thesis), Non-coding RNAs, Lundberg Laboratory, Göteborg University, Göteborg, Sweden.
2000 – 2003: Engineer in Design and Research Centre, Iran Six Star Co., Tehran, Iran.
1999 – 2000: Medical Engineer, Mofid Hospital, Tehran, Iran.
1998 – 1999: Research (bachelor thesis), eliminating noise from EEG signals in the Neurology department of Shohadaye Tajrish Hospital, Tehran, Iran.
1997 – 1998: Engineer, Electronic factory, Tehran, Iran.
Research interests/projects:
Bioinformatics (RNA-seq, whole-genome and targeted sequencing in cancer research), statistical analysis, machine learning
Publications 2024
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
J Immunother Cancer, 12 (4)
DOI 10.1136/jitc-2023-008179, PubMed 38604812
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
Cell Rep Med, 5 (6), 101572
DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
Publications 2022
The barriers to whole-grain consumption among Iranian students
Sci Rep, 12 (1), 15224
DOI 10.1038/s41598-022-19606-6, PubMed 36076004
Publications 2021
The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
J Pers Med, 11 (5)
DOI 10.3390/jpm11050330, PubMed 33922147
Effect of educational intervention on preventive behaviors of brucellosis among health volunteers in Rafsanjan city: Application of health belief model
J Educ Health Promot, 10, 369
DOI 10.4103/jehp.jehp_1256_20, PubMed 34912905
Publications 2020
Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors
JCI Insight, 5 (12)
DOI 10.1172/jci.insight.137495, PubMed 32365348
Publications 2018
Correction to: A systematic comparison of copy number alterations in four types of female cancer
BMC Cancer, 18 (1), 80
DOI 10.1186/s12885-017-3766-7, PubMed 29338700
Publications 2017
Comparison of Cone Beam Computed Tomography and Multi Slice Computed Tomography Image Quality of Human Dried Mandible using 10 Anatomical Landmarks
J Clin Diagn Res, 11 (2), ZC13-ZC16
DOI 10.7860/JCDR/2017/20637.9253, PubMed 28384972
Publications 2016
Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
J Hepatol, 66 (1), 116-122
DOI 10.1016/j.jhep.2016.09.002, PubMed 27647428
A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
Am J Gastroenterol, 111 (10), 1467-1475
DOI 10.1038/ajg.2016.329, PubMed 27527747
A systematic comparison of copy number alterations in four types of female cancer
BMC Cancer, 16 (1), 913
DOI 10.1186/s12885-016-2899-4, PubMed 27876019
Publications 2015
High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
Hepatology, 63 (5), 1608-19
DOI 10.1002/hep.28116, PubMed 26257205
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
Breast Cancer Res, 17 (1), 44
DOI 10.1186/s13058-015-0548-5, PubMed 25882602
Publications 2011
Allele-specific disparity in breast cancer
BMC Med Genomics, 4, 85
DOI 10.1186/1755-8794-4-85, PubMed 22188678